if the company is willing to reward the CEO US$17.3 mil/year just to get some patients for trials and preparation of the recell 2.0 application, this tech must be worth of hundreds of billion $.
Your explanation of why rcel is not used in AU is bizarre!
- Forums
- ASX - By Stock
- AVH
- Ann: Change of Director's Interest Notice - Michael Perry
Ann: Change of Director's Interest Notice - Michael Perry, page-40
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVH (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.74 |
Change
0.110(4.18%) |
Mkt cap ! $186.5M |
Open | High | Low | Value | Volume |
$2.74 | $2.77 | $2.66 | $902.2K | 331.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 2136 | $2.73 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.75 | 2141 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 2136 | 2.730 |
5 | 6131 | 2.720 |
3 | 5071 | 2.710 |
3 | 36189 | 2.700 |
1 | 3000 | 2.690 |
Price($) | Vol. | No. |
---|---|---|
2.750 | 2141 | 3 |
2.760 | 6747 | 5 |
2.770 | 20029 | 4 |
2.780 | 19158 | 3 |
2.790 | 3212 | 2 |
Last trade - 14.38pm 15/07/2024 (20 minute delay) ? |
Featured News
AVH (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online